A detailed history of Great Lakes Advisors, LLC transactions in Incyte Corp stock. As of the latest transaction made, Great Lakes Advisors, LLC holds 5,822 shares of INCY stock, worth $393,276. This represents 0.0% of its overall portfolio holdings.

Number of Shares
5,822
Previous 4,153 40.19%
Holding current value
$393,276
Previous $251,000 52.99%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$57.33 - $68.61 $95,683 - $114,510
1,669 Added 40.19%
5,822 $384,000
Q2 2024

Aug 05, 2024

SELL
$51.18 - $63.75 $1.54 Million - $1.91 Million
-30,004 Reduced 87.84%
4,153 $251,000
Q1 2024

May 08, 2024

BUY
$56.55 - $66.59 $100,376 - $118,197
1,775 Added 5.48%
34,157 $1.95 Million
Q4 2023

Feb 08, 2024

BUY
$52.16 - $64.19 $1.69 Million - $2.08 Million
32,382 New
32,382 $2.03 Million
Q3 2021

Nov 09, 2021

SELL
$68.67 - $84.02 $2.22 Million - $2.71 Million
-32,287 Closed
0 $0
Q2 2021

Aug 11, 2021

SELL
$79.87 - $87.53 $375,548 - $411,566
-4,702 Reduced 12.71%
32,287 $2.72 Million
Q1 2021

May 03, 2021

BUY
$76.02 - $100.5 $2.81 Million - $3.72 Million
36,989 New
36,989 $3.01 Million
Q2 2019

Aug 05, 2019

SELL
$73.52 - $88.7 $687,485 - $829,433
-9,351 Closed
0 $0
Q1 2019

May 07, 2019

BUY
$63.56 - $88.17 $115,742 - $160,557
1,821 Added 24.18%
9,351 $804,000
Q4 2018

Feb 13, 2019

BUY
$58.5 - $69.94 $227,974 - $272,556
3,897 Added 107.27%
7,530 $479,000
Q3 2018

Nov 15, 2018

BUY
$61.75 - $74.23 $224,337 - $269,677
3,633 New
3,633 $251,000
Q1 2018

May 07, 2018

SELL
$83.06 - $100.98 $603,763 - $734,023
-7,269 Closed
0 $0
Q4 2017

Feb 08, 2018

SELL
$93.56 - $116.6 $241,852 - $301,411
-2,585 Reduced 26.23%
7,269 $688,000
Q3 2017

Nov 13, 2017

BUY
$109.15 - $138.27 $1.08 Million - $1.36 Million
9,854
9,854 $1.15 Million

Others Institutions Holding INCY

About INCYTE CORP


  • Ticker INCY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 222,431,008
  • Market Cap $15B
  • Description
  • Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...
More about INCY
Track This Portfolio

Track Great Lakes Advisors, LLC Portfolio

Follow Great Lakes Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great Lakes Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Great Lakes Advisors, LLC with notifications on news.